Related Experiment Video
Updated: Aug 13, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Congenital dyserythropoietic anaemia type I. Report of two siblings from Saudi Arabia
I M al-Fawaz1, S A al-Mashhadani
1Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Insights
This study reports on two siblings with congenital dyserythropoietic anaemia type I (CDAI). This seventh familial occurrence highlights variable presentation of CDAI, impacting diagnosis and treatment.
Area of Science:
- Hematology
- Genetics
- Pediatrics
Background:
- Congenital dyserythropoietic anaemia type I (CDAI) is a rare inherited blood disorder.
- Understanding familial occurrences is crucial for genetic counseling and disease management.
Observation:
- Two siblings, a brother and sister, presented with CDAI.
- The sister showed symptoms in the neonatal period, requiring transfusions.
- The brother presented later with less severe symptoms, avoiding transfusions.
Findings:
- This case represents the seventh reported familial occurrence of CDAI.
- The siblings exhibited variable clinical severity and age of onset.
- Clinical presentation ranged from neonatal jaundice and hepatosplenomegaly to later-onset anemia.
Implications:
- Highlights the genetic heterogeneity and variable expressivity of CDAI.
- Emphasizes the importance of family history in diagnosing rare genetic anemias.
- Informs potential therapeutic strategies and prognostic assessments for CDAI patients.
Abstract:
This study describes two siblings (a boy and a girl) affected with congenital dyserythropoietic anaemia type I. It is the seventh familial occurrence reported. The girl presented in the neonatal period with anaemia, jaundice and hepatosplenomegaly and required 4 blood transfusions in the first 7 months of life, while her brother was discovered to be anaemic and jaundiced only at the age of 2 years and did not receive any blood transfusion.
More Related Videos
Related Concept Videos
Pedigree Analysis
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Jaundice

